EUVIMEDEUVIMED entdecken
Crossref

Senolysis Enabled by Senescent Cell‐Sensitive Bioorthogonal Tetrazine Ligation

Mengyang Chang, Yue Dong, Hang Xu, Alexis B. Cruickshank‐Taylor, Jacob S. Kozora, Baran Behpour, Wei Wang

Angewandte Chemie · 26.02.2024 · 136 (9)

DOI: 10.1002/ange.202315425 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie, online erschienen am 30.01.2024. Verfasst von Mengyang Chang und 6 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 80 Literaturangaben. Gefördert von: National Institute of General Medical Sciences, University of Arizona.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although the clearance of senescent cells has been proven to slow down the aging process and promote anti‐cancer chemotherapy, the development of senolytics remains challenging. Herein, we report a senolytic strategy enabled by senescent cell‐sensitive bioorthogonal tetrazine ligation. Our design is based on linking dihydrotetrazine (Tz) to a galactose (Gal) moiety that serves both as a recognition moiety for senescence‐associated β‐galactosidase and a caging group for the control of tetrazine activity. Gal‐Tz enables efficient click‐release of a fluorescent hemicyanine and doxorubicin from a trans ‐cyclooctene‐caged prodrug to detect and eliminate senescent HeLa and A549 cells over non‐senescent counterparts with a 16.44 senolytic index. Furthermore, we leverage the strategy for the selective activation and delivery of proteolysis‐targeting chimeras (PROTACs) as senolytics. PROTAC prodrug TCO‐ARV‐771 can be selectively activated by Gal‐Tz and delivered into senescent HeLa and A549 cells to induce the degradation of bromodomain‐containing protein 4. Senolytic PROTACs may offer an efficient way for intervention on cell senescence thanks to their unique capacity to degrade target proteins in a sub‐stoichiometric and catalytic fashion. The results of this study establish the bioorthogonal tetrazine ligation approach as a viable strategy for selective removal of senescent cells.

Förderung

  • National Institute of General Medical Sciences
  • University of Arizona

Zitieren

APA

Chang, M., Dong, Y., Xu, H., Cruickshank‐Taylor, A. B., Kozora, J. S., Behpour, B., & Wang, W. (2024). Senolysis Enabled by Senescent Cell‐Sensitive Bioorthogonal Tetrazine Ligation. Angewandte Chemie, 136(9). https://doi.org/10.1002/ange.202315425

Vancouver

Chang M, Dong Y, Xu H, Cruickshank‐Taylor AB, Kozora JS, Behpour B, et al. Senolysis Enabled by Senescent Cell‐Sensitive Bioorthogonal Tetrazine Ligation. Angewandte Chemie. 2024;136(9). doi:10.1002/ange.202315425

BibTeX
@article{Chang2024,
  author = {Chang, Mengyang and Dong, Yue and Xu, Hang and Cruickshank‐Taylor, Alexis B. and Kozora, Jacob S. and Behpour, Baran and Wang, Wei},
  title = {Senolysis Enabled by Senescent Cell‐Sensitive Bioorthogonal Tetrazine Ligation},
  journal = {Angewandte Chemie},
  year = {2024},
  volume = {136},
  number = {9},
  doi = {10.1002/ange.202315425}
}
Kostenlos starten →